Replies to post #201740 on Biotech Values

[DewDiligence]

RVNC—Nice bounce-back from yesterday’s sell-off:

$RVNC nice bouce-back. Either investors decided $DERM not bona fide competitor, or yesterday's sell-off had nothing2do w $DERM. @zbiotech

— Roy Friedman (@DewDiligence) June 2, 2016

[DewDiligence]

DERM sells 5.18M* shares @$28.00—a 7% discount to yesterday’s close:

http://finance.yahoo.com/news/dermira-prices-126-million-public-110000698.html

*Assuming exercise of underwriter’s option.